Kerrisdale Capital

Kerrisdale Capital is a New York-based private investment management firm focused on value-oriented investing in public securities, with strategies spanning both long and short positions. The firm is best known for research-driven activist short reports and fundamental analysis across sectors including technology, financial services, consumer, and healthcare. Founded in 2009 by Sahm Adrangi, Kerrisdale operates as an investment partnership rather than a drug developer, service provider, or healthcare operating company. While it has published research on healthcare and biotech companies, it is not itself a life sciences, biotech, pharma, or healthcare company.